Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bacon

Showing results (11-20 of 467) with videos related to

Pageof 47
Sort By:
Current Opinion in Rheumatology|February 1, 1990
Vasculitic syndromes associated with other rheumatic conditions and unclassified systemic vasculitisP A Bacon
Rheumatology International|January 1, 1990
Etodolac: efficacy in osteoarthritis and effects on chondrocyte functionP A Bacon
Hospital Pharmacy|January 10, 1985
Twenty-four hour pharmacy service in hospitals with less than 300 beds--part 10D A Bacon
Agents and Actions. Supplements|January 1, 1980
The use of thermography in the assessment of anti-inflammatory drugsP A Bacon
Rheumatology and Rehabilitation|January 1, 1979
Circulating immune complexes in systemic rheumatoid diseaseP A Bacon
Current Opinion in Rheumatology|December 18, 2004
Endothelial cell dysfunction in systemic vasculitis: new developments and therapeutic prospectsP A Bacon
Rheumatology and Rehabilitation|January 1, 1978
Drug therapy and circulating immune complexes in rheumatoid arthritisP A Bacon
The New England Journal of Medicine|January 28, 2005
The spectrum of Wegener's granulomatosis and disease relapsePaul A Bacon
European Journal of Rheumatology and Inflammation|January 1, 1990
An overview of the efficacy of etodolac in arthritic disordersP A Bacon
Current Opinion in Rheumatology|January 1, 1993
Systemic vasculitic syndromesP A Bacon
Pageof 47

Showing results (11-20 of 467) with videos related to

Sort By:
Pageof 47
Current Opinion in Rheumatology|February 1, 1990
Vasculitic syndromes associated with other rheumatic conditions and unclassified systemic vasculitisP A Bacon
Rheumatology International|January 1, 1990
Etodolac: efficacy in osteoarthritis and effects on chondrocyte functionP A Bacon
Hospital Pharmacy|January 10, 1985
Twenty-four hour pharmacy service in hospitals with less than 300 beds--part 10D A Bacon
Agents and Actions. Supplements|January 1, 1980
The use of thermography in the assessment of anti-inflammatory drugsP A Bacon
Rheumatology and Rehabilitation|January 1, 1979
Circulating immune complexes in systemic rheumatoid diseaseP A Bacon
Current Opinion in Rheumatology|December 18, 2004
Endothelial cell dysfunction in systemic vasculitis: new developments and therapeutic prospectsP A Bacon
Rheumatology and Rehabilitation|January 1, 1978
Drug therapy and circulating immune complexes in rheumatoid arthritisP A Bacon
The New England Journal of Medicine|January 28, 2005
The spectrum of Wegener's granulomatosis and disease relapsePaul A Bacon
European Journal of Rheumatology and Inflammation|January 1, 1990
An overview of the efficacy of etodolac in arthritic disordersP A Bacon
Current Opinion in Rheumatology|January 1, 1993
Systemic vasculitic syndromesP A Bacon
Pageof 47